The stock price of Johnson & Johnson (JNJ) on the NYSE is currently at $160.61, experiencing a decrease of 0.23% as of 11:19 AM EST. The stock opened at $161.00 and has a day’s range of $160.49 to $161.32. Over the past 52 weeks, the stock has traded between $144.95 and $175.97. The trading volume for JNJ is 1,767,589 shares, with an average volume of 7,290,250 shares. The market capitalization of Johnson & Johnson is $386.873 billion. The stock has a beta of 0.54 and a price-to-earnings ratio (TTM) of 30.89. The earnings per share (TTM) is $5.20. The forward dividend yield is 2.96%, with an ex-dividend date of February 16, 2024. The 1-year target estimate for JNJ is $175.05.
Johnson & Johnson is a diversified healthcare company that operates in two business segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on products for various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment provides interventional solutions, heart recovery technologies, neurovascular care, orthopaedics, surgery portfolios, contact lenses, and intraocular lenses for cataract surgery.
Johnson & Johnson is headquartered in New Brunswick, New Jersey, and has a full-time employee count that is not specified. The company distributes its products globally to wholesalers, hospitals, retailers, physicians, nurses, eye care professionals, and clinics.
Please note that the stock market data on this page may be delayed due to temporary issues.
